Smooth muscle α 1D-adrenoceptors mediate phenylephrine-induced vasoconstriction and increases in endothelial cell Ca 2+ in hamster cremaster arterioles

British Journal of Pharmacology

Volumn 155, Issue 4, 2008, Pages 514-524

  Jackson, W F ^a   Boerman, E M ^a   Lange, E J ^a   Lundback, S S ^a   Cohen, K D ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b KENNEDY SPACE CENTER   (United States)

Author keywords

BMY 7378 5 methylurapidil; Ca 2+ signalling; Cell cell communication; Endothelium; L 765314; Microcirculation; Prazosin; Vasoconstriction

Indexed keywords

5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; CALCIUM ION; FURA 2; METHACHOLINE; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTERIOLE; ARTERY CONSTRICTION; ARTICLE; CALCIUM SIGNALING; CELL INTERACTION; CONTROLLED STUDY; CREMASTER MUSCLE; HAMSTER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; ANIMAL; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION; METABOLISM; VASOCONSTRICTION; WESTERN BLOTTING;

ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ADRENERGIC ALPHA-AGONISTS; ANIMALS; ARTERIOLES; BLOTTING, WESTERN; CALCIUM; CRICETINAE; ENDOTHELIAL CELLS; GENE EXPRESSION; MALE; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 53849144277     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.276     Document Type: Article

References (43)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to receptors and channels, 3rd edn. Br J Pharmacol 153 (Suppl 2): S1-S209.
2. 2+ dynamics during blood flow control in hamster cheek pouch. J Appl Physiol 101: 307-315.
3. + channels. Microcirculation 11: 279-293.
4. 1D receptor. Bioorg Med Chem Lett 11: 1119-1121.
5. Cohen KD, Jackson WF (2003). Hypoxia inhibits contraction but not calcium channel currents or changes in intracellular calcium in arteriolar muscle cells. Microcirculation 10: 133-141.
6. 2+ in arteriolar endothelial cells. Microcirculation 12: 169-182.
7. Cotecchia S, Schwinn DA, Randall RR, Lefkowitz RJ, Caron MG, Kobilka BK (1988). Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor. Proc Natl Acad Sci USA 85: 7159-7163.
8. Daly CJ, Deighan C, McGee A, Mennie D, Ali Z, McBride M et al. (2002). A knockout approach indicates a minor vasoconstrictor role for vascular alpha1B-adrenoceptors in mouse. Physiol Genomics 9: 85-91.
9. Deng XF, Chemtob S, Varma DR (1996). Characterization of alpha 1 D-adrenoceptor subtype in rat myocardium, aorta and other tissues. Br J Pharmacol 119: 269-276.
10. Dora KA, Doyle MP, Duling BR (1997). Elevation of intracellular calcium in smooth muscle causes endothelial cell generation of NO in arterioles. Proc Natl Acad Sci USA 94: 6529-6534.
11. Dora KA, Hinton JM, Walker SD, Garland CJ (2000). An indirect influence of phenylephrine on the release of endothelium-derived vasodilators in rat small mesenteric artery. Br J Pharmacol 129: 381-387.
12. Falcone JC, Kuo L, Meininger GA (1993). Endothelial cell calcium increases during flow-induced dilation in isolated arterioles. Am J Physiol Heart Circ Physiol 264: H653-H659.
13. Filippi S, Parenti A, Donnini S, Granger HJ, Fazzini A, Ledda F (2001). alpha(1D)-adrenoceptors cause endothelium-dependent vasodilatation in the rat mesenteric vascular bed. J Pharmacol Exp Ther 296: 869-875.
14. Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD et al. (1997). Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol 121: 1127-1135.
15. Gisbert R, Madrero Y, Sabino V, Noguera MA, Ivorra MD, D'Ocon P (2003). Functional characterization of alpha 1-adrenoceptor subtypes in vascular tissues using different experimental approaches: a comparative study. Br J Pharmacol 138: 359-368.
16. Goetz AS, King HK, Ward SD, True TA, Rimele TJ, Saussy Jr DL (1995). BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors. Eur J Pharmacol 272: R5-R6.
17. Gross G, Hanft G, Rugevics C (1988). 5-Methyl-urapidil discriminates between subtypes of the alpha 1-adrenoceptor. Eur J Pharmacol 151: 333-335.
18. Heijnen CJ, Rouppe van der Voort C, van de Pol M, Kavelaars A (2002). Cytokines regulate alpha(1)-adrenergic receptor mRNA expression in human monocytic cells and endothelial cells. J Neuroimmunol 125: 66-72.
19. Hosoda C, Koshimizu TA, Tanoue A, Nasa Y, Oikawa R, Tomabechi T et al. (2005). Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation. Mol Pharmacol 67: 912-922.
20. Hrometz SL, Edelmann SE, McCune DF, Olges JR, Hadley RW, Perez DM et al. (1999). Expression of multiple alpha1-adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction. J Pharmacol Exp Ther 290: 452-463.
21. Hussain MB, Marshall I (1997). Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery. Br J Pharmacol 122: 849-858.
22. 2+ and inositol 1,4,5-trisphosphate-mediated signaling across the myoendothelial junction. Circ Res 100: 246-254.
23. Jackson WF, Huebner JM, Rusch NJ (1997). Enzymatic isolation and characterization of single vascular smooth muscle cells from cremasteric arterioles. Microcirculation 4: 35-50.
24. Jarajapu YP, Coats P, McGrath JC, Hillier C, MacDonald A (2001a). Functional characterization of alpha(1)-adrenoceptor subtypes in human skeletal muscle resistance arteries. Br J Pharmacol 133: 679-686.
25. Jarajapu YP, Johnston F, Berry C, Renwick A, McGrath JC, MacDonald A et al. (2001b). Functional characterization of alpha1-adrenoceptor subtypes in human subcutaneous resistance arteries. J Pharmacol Exp Ther 299: 729-734.
26. Kenny BA, Chalmers DH, Philpott PC, Naylor AM (1995). Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br J Pharmacol 115: 981-986.
27. Lachnit WG, Tran AM, Clarke DE, Ford AP (1997). Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br J Pharmacol 120: 819-826.
28. Lamboley M, Pittet P, Koenigsberger M, Sauser R, Beny J-L, Meister J-J (2005). Evidence for signaling via gap junctions from smooth muscle to endothelial cells in rat mesenteric arteries: possible implication of a second messenger. Cell Calcium 37: 311.
29. Leech CJ, Faber JE (1996). Different alpha-adrenoceptor subtypes mediate constriction of arterioles and venules. Am J Physiol 270: H710-H722.
30. Marrelli SP (2000). Selective measurement of endothelial or smooth muscle [Ca(2+)](i) in pressurized/perfused cerebral arteries with fura-2. J Neurosci Methods 97: 145-155.
31. Marti D, Miquel R, Ziani K, Gisbert R, Ivorra MD, Anselmi E et al. (2005). Correlation between mRNA levels and functional role of alpha1-adrenoceptor subtypes in arteries: evidence of alpha1L as a functional isoform of the alpha1A-adrenoceptor. Am J Physiol Heart Circ Physiol 289: H1923-H1932.
32. Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J et al. (1998). 4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)-[[(1,1- dimethylethyl) amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314): a potent and selective alpha1b adrenergic receptor antagonist. J Med Chem 41: 1205-1208.
33. Rokosh DG, Simpson PC (2002). Knockout of the alpha 1A/Cadrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 99: 9474-9479.
34. Sandow SL, Hill CE (2000). Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor-mediated responses. Circ Res 86: 341-346.
35. Schuster A, Oishi H, Beny JL, Stergiopulos N, Meister JJ (2001). Simultaneous arterial calcium dynamics and diameter measurements: application to myoendothelial communication. Am J Physiol Heart Circ Physiol 280: H1088-H1096.
36. Schwinn DA, Johnston GI, Page SO, Mosley MJ, Wilson KH, Worman NP et al. (1995). Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J Pharmacol Exp Ther 272: 134-142.
37. Tuttle JL, Falcone JC (2001). Nitric oxide release during alpha1-adrenoceptor-mediated constriction of arterioles. Am J Physiol Heart Circ Physiol 281: H873-H881.
38. Vinci MC, Bellik L, Filippi S, Ledda F, Parenti A (2007). Trophic effects induced by alpha1D-adrenoceptors on endothelial cells are potentiated by hypoxia. Am J Physiol Heart Circ Physiol 293: H2140-H2147.
39. 2+ rise in endothelial cells from bovine adrenal medulla. Mol Cell Biochem 203: 53-58.
40. Yashiro Y, Duling BR (2000). Integrated Ca(2+) signaling between smooth muscle and endothelium of resistance vessels. Circ Res 87: 1048-1054.
41. Yoshio R, Taniguchi T, Itoh H, Muramatsu I (2001). Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes. Jpn J Pharmacol 86: 189-195.
42. Zacharia J, Hillier C, MacDonald A (2004). Alpha1-adrenoceptor subtypes involved in vasoconstrictor responses to exogenous and neurally released noradrenaline in rat femoral resistance arteries. Br J Pharmacol 141: 915-924.
43. Zhu W, Zhang Y, Han C (1997). Characterization of subtype of alpha1-adrenoceptor mediating vasoconstriction in perfused rat hind limb. Eur J Pharmacol 329: 55-61.